ALPHAVOG 0.2MG TABLET 10S

Product Introduction:

AlphaVog 0.2mg Tablet contains Voglibose as its active ingredient. Voglibose is an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. It works by delaying the digestion and absorption of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.

AlphaVog 0.2mg Tablet should be taken just before a meal. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. Do not stop taking it suddenly without consulting your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.

This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Monitor your blood sugar levels regularly while taking this medicine.

The most common side effects of AlphaVog 0.2mg Tablet include flatulence (gas), stomach pain, loss of appetite, constipation, and diarrhea. Consult your doctor if any of these side effects bother you or do not go away. This medicine by itself does not cause hypoglycemia (low blood sugar levels). However, when used in combination with other diabetes medicines (especially insulin or sulphonylureas), it can lead to hypoglycemia (low blood sugar levels). Such episodes of hypoglycemia will have to be treated by taking plain glucose. Table sugar or common sugar will not help correct low blood sugar levels if you are taking this medicine.

Before taking it, let your doctor know if you have any kidney or liver problems. Do not take this medicine if you have ulceration or inflammation in the bowel (eg. ulcerative colitis or Crohn’s disease). Pregnant or breastfeeding women should also consult their doctor before taking it. Please tell your doctor about all the other medicines you are taking to make sure you are safe. Avoid excessive alcohol intake while taking this medicine as it may increase the risk of hypoglycemia (low blood sugar levels).

Benefits:

1. Blood Glucose Control: AlphaVog 0.2mg Tablet helps in controlling postprandial blood glucose levels in patients with type 2 diabetes mellitus.
2. Reduced Glycemic Variability: By slowing down carbohydrate digestion, it can help reduce spikes in blood sugar levels after meals.
3. Weight Management: Unlike some other antidiabetic medications, Voglibose is not associated with weight gain and may even help in weight management.
4. Cardiovascular Benefits: Some studies suggest that Voglibose may have cardiovascular benefits beyond glycemic control.

Side Effects:

Common side effects of AlphaVog 0.2mg Tablet may include:

1. Flatulence: Increased gas production and flatulence are common side effects due to undigested carbohydrates reaching the colon.
2. Abdominal Discomfort: Some individuals may experience abdominal discomfort, bloating, or cramping.
3. Diarrhea: Voglibose may cause diarrhea in some patients, especially when starting the medication.
4. Hypoglycemia: While uncommon, hypoglycemia (low blood sugar) may occur, particularly if Voglibose is taken with other antidiabetic medications.

Usage Guidelines:

1. Dosage: The usual recommended dosage of AlphaVog 0.2mg Tablet is one tablet taken orally three times a day, immediately before each main meal.
2. Administration: Swallow the tablet whole with a glass of water. It is typically taken before meals to inhibit the digestion of carbohydrates.
3. Dietary Considerations: Patients should follow a balanced diet and meal plan as recommended by their healthcare provider while taking Voglibose.
4. Monitoring: Regular monitoring of blood glucose levels is essential to adjust the dosage of Voglibose as needed and to prevent hypoglycemia.

Drug Interactions:

1. Sulfonylureas: Concurrent use of Voglibose with sulfonylureas may increase the risk of hypoglycemia.
2. Insulin: Combining Voglibose with insulin may also increase the risk of hypoglycemia and may require adjustments in insulin dosage.
3. Alpha-Glucosidase Inhibitors: Co-administration of Voglibose with other alpha-glucosidase inhibitors may lead to additive effects on reducing postprandial blood glucose levels.
4. Digoxin: Voglibose may delay the absorption of digoxin, necessitating close monitoring of digoxin levels and potential adjustments in dosage.

Before starting AlphaVog 0.2mg Tablet, patients should inform their healthcare provider about all medications, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions. It’s essential to adhere to the prescribed dosage and dietary recommendations for optimal efficacy and safety. Any concerns or adverse effects should be promptly reported to the healthcare provider.

SAFETY ADVICE

Alcohol

UNSAFE

It is unsafe to consume alcohol with AlphaVog 0.2mg Tablet.

Pregnancy

SAFE IF PRESCRIBED

AlphaVog 0.2mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

SAFE IF PRESCRIBED

AlphaVog 0.2mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

SAFE

AlphaVog 0.2mg Tablet does not usually affect your ability to drive.

Kidney

CAUTION

AlphaVog 0.2mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of AlphaVog 0.2mg Tablet may be needed. Please consult your doctor.

Liver

CAUTION

AlphaVog 0.2mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of AlphaVog 0.2mg Tablet may be needed. Please consult your doctor.